The store will not work correctly when cookies are disabled.
1-Methyl-2-[2-oxo-3,4-dihydro-2H-naphthalen-(1E)-ylidenemethyl]-piperidinium
ID: ALA609146
PubChem CID: 44350132
Max Phase: Preclinical
Molecular Formula: C17H21NO
Molecular Weight: 255.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCCCC1/C=C1/C(=O)CCc2ccccc21
Standard InChI: InChI=1S/C17H21NO/c1-18-11-5-4-7-14(18)12-16-15-8-3-2-6-13(15)9-10-17(16)19/h2-3,6,8,12,14H,4-5,7,9-11H2,1H3/b16-12+
Standard InChI Key: IKOISXUHUSCVOV-FOWTUZBSSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
-0.0159 0.2594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0159 1.0844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6985 2.3219 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6985 -0.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6985 1.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7304 -0.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6985 -0.9781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7304 -0.9781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4449 0.2594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0159 -1.3906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0159 2.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4130 2.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4130 0.2594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4130 1.0844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4130 -1.3906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1275 2.3219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1275 -0.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1275 1.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1275 -0.9781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 5 1 0
4 1 1 0
5 2 1 0
6 1 1 0
7 4 2 0
8 6 1 0
9 6 2 0
10 8 1 0
11 3 1 0
12 3 1 0
13 4 1 0
14 5 1 0
15 7 1 0
16 18 1 0
17 13 2 0
18 14 1 0
19 17 1 0
7 10 1 0
19 15 2 0
16 12 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 255.36 | Molecular Weight (Monoisotopic): 255.1623 | AlogP: 3.07 | #Rotatable Bonds: 1 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.82 | CX LogP: 3.56 | CX LogD: 3.00 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.72 | Np Likeness Score: 0.25 |
References
1. Villeneuve G, Cécyre D, Lejeune H, Drouin M, Lan R, Quirion R.. (2003) Rigidified acetylcholine mimics: conformational requirements for binding to neuronal nicotinic receptors., 13 (21): [PMID:14552793] [10.1016/s0960-894x(03)00728-5] |